trial
as of 2026-07-01Glutamate, Brain Connectivity and Duration of Untreated Psychosis
NCTId NCT02034253
at a glance
Phase — · Completed
Enrollment 134 (actual)
Sponsored by University of Alabama at Birmingham
Primary completion 2018-11
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
134 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2014-01
Primary completion
2018-11
Eligibility
ALL · 17 Years · 35 Years
Interventions & indications
Sponsors
University of Alabama at BirminghamLead Sponsor
Investigators
1
Adrienne C. Lahti, MDPrincipal Investigator
Sites
1 total
Birmingham, United States
Facts & assertions
4 sourced
Enrollment
134
Phase
NA
Primary Completion Date
2018-11
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator
person